Hazard Curves for Tumor Recurrence and Tumor-Related Death Following Esophagectomy for Esophageal Cancer

被引:16
作者
Lindenmann, Joerg [1 ]
Fediuk, Melanie [1 ]
Fink-Neuboeck, Nicole [1 ]
Porubsky, Christian [1 ]
Pichler, Martin [2 ,3 ]
Brcic, Luka [4 ]
Anegg, Udo [1 ]
Balic, Marija [3 ]
Dandachi, Nadia [3 ]
Maier, Alfred [1 ]
Smolle, Maria [5 ]
Smolle, Josef [6 ]
Smolle-Juettner, Freyja Maria [1 ]
机构
[1] Med Univ Graz, Div Thorac & Hyperbar Surg, Dept Surg, A-8036 Graz, Austria
[2] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Expt Therapeut, UTHlth,Texas A&M Coll Med, Houston, TX 77030 USA
[3] Med Univ Graz, Div Oncol, Dept Internal Med, A-8036 Graz, Austria
[4] Med Univ Graz, Diagnost & Res Inst Pathol, A-8036 Graz, Austria
[5] Med Univ Graz, Dept Orthopaed & Trauma, A-8036 Graz, Austria
[6] Med Univ Graz, Inst Med Informat Stat & Documentat, A-8036 Graz, Austria
关键词
esophageal cancer; esophagectomy; tumor recurrence; hazard; surveillance; survival; NEOADJUVANT CHEMORADIOTHERAPY; PREOPERATIVE CHEMORADIOTHERAPY; SURVIVAL; CARCINOMA; SURGERY; PATTERNS; DIAGNOSIS; TIME;
D O I
10.3390/cancers12082066
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The knowledge of both patterns and risk of relapse following resection for esophageal cancer is crucial for establishing appropriate surveillance schedules. The aim of this study was to evaluate the pattern of hazards for tumor recurrence and tumor-related death in the postoperative long-term follow-up after esophagectomy. Methods: Retrospective single-center analysis of 362 patients, with resected esophageal cancer. Multivariate Cox proportional hazard model was used. Results: A total of 192 (53%) had postoperative tumor recurrence. The relapse patterns of adenocarcinoma and squamous-cell carcinoma showed that each had a single peak, 12 months after surgery. After induction there was one peak at 5 months, the non-induced patients peaked 11 months, postoperatively. At 18 months, the recurrence hazard declined sharply in all cases. The hazard curves for tumor-related death were bimodal for adenocarcinoma, with two peaks at 6 and 22 months and one single peak for squamous-cell carcinoma at 18 months after surgery, showing pronounced decline later on. Conclusion: In curatively resected esophageal cancer, both tumor recurrence hazard and hazard for tumor-related death showed distinct, partly bimodal patterns. It could be justified to intensify the surveillance during the first two postoperative years by initiating a close-meshed follow-up to detect and treat tumor recurrence, as early as possible.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 35 条
[1]   Esophageal and Esophagogastric Junction Cancers, Version 2.2019 [J].
Ajani, Jaffer A. ;
D'Amico, Thomas A. ;
Bentrem, David J. ;
Chao, Joseph ;
Corvera, Carlos ;
Das, Prajnan ;
Denlinger, Crystal S. ;
Enzinger, Peter C. ;
Fanta, Paul ;
Farjah, Farhood ;
Gerdes, Hans ;
Gibson, Michael ;
Glasgow, Robert E. ;
Hayman, James A. ;
Hochwald, Steven ;
Hofstetter, Wayne L. ;
Ilson, David H. ;
Jaroszewski, Dawn ;
Johung, Kimberly L. ;
Keswani, Rajesh N. ;
Kleinberg, Lawrence R. ;
Leong, Stephen ;
Ly, Quan P. ;
Matkowskyj, Kristina A. ;
McNamara, Michael ;
Mulcahy, Mary F. ;
Paluri, Ravi K. ;
Park, Haeseong ;
Perry, Kyle A. ;
Pimiento, Jose ;
Poultsides, George A. ;
Roses, Robert ;
Strong, Vivian E. ;
Wiesner, Georgia ;
Willett, Christopher G. ;
Wright, Cameron D. ;
McMillian, Nicole R. ;
Pluchino, Lenora A. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (07) :855-883
[2]   Patterns and risk of recurrence in patients with esophageal cancer with a pathologic complete response after chemoradiotherapy followed by surgery [J].
Lin, Jules ;
Barbetta, Arianna ;
Molena, Daniela ;
Raja, Siva ;
Stiles, Brendon ;
Litle, Virginia .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 157 (03) :1257-+
[3]   Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival [J].
Berger, AC ;
Farma, J ;
Scott, WJ ;
Freedman, G ;
Weiner, L ;
Cheng, JD ;
Wang, H ;
Goldberg, M .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (19) :4330-4337
[4]   Does neoadjuvant chemoradiotherapy increase survival in patients with resectable oesophageal cancer? [J].
Buderi, Silviu I. ;
Shackcloth, Michael ;
Page, Richard D. .
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2017, 24 (01) :115-120
[5]   Barrett's esophagus and esophageal cancer: An overview [J].
Conteduca, Vincenza ;
Sansonno, Domenico ;
Ingravallo, Giuseppe ;
Marangi, Stefania ;
Russi, Sabino ;
Lauletta, Gianfranco ;
Dammacco, Franco .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 41 (02) :414-424
[6]   Mckeown esophagogastrectomy [J].
D'Amico, Thomas A. .
JOURNAL OF THORACIC DISEASE, 2014, 6 :S322-S324
[7]   Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer [J].
Dignam, James J. ;
Dukic, Vanja ;
Anderson, Stewart J. ;
Mamounas, Eleftherios P. ;
Wickerham, D. Lawrence ;
Wolmark, Norman .
BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (03) :595-602
[8]   Hazards of Recurrence, Second Primary, or Other Tumor at Ten Years After Surgery for Non-Small-Cell Lung Cancer [J].
Fink-Neuboeck, Nicole ;
Lindenmann, Joerg ;
Porubsky, Christian ;
Fediuk, Melanie ;
Anegg, Udo ;
Maier, Alfred ;
Smolle, Josef ;
Lamont, Eugenia ;
Smolle-Juettner, Freyja Maria .
CLINICAL LUNG CANCER, 2020, 21 (04) :333-340
[9]   Preoperative chemoradiotherapy for oesophageal cancer:: a systematic review and meta-analysis [J].
Fiorica, F ;
Di Bona, D ;
Schepis, F ;
Licata, A ;
Shahied, L ;
Venturi, A ;
Falchi, AM ;
Craxí, A ;
Cammà, C .
GUT, 2004, 53 (07) :925-930
[10]   Clinical study on postoperative recurrence in patients with pN1 esophageal squamous cell carcinoma [J].
Guo, Xufeng ;
Mao, Teng ;
Gu, Zhitao ;
Ji, Chunyu ;
Fang, Wentao .
THORACIC CANCER, 2015, 6 (02) :146-150